cdmo.directory
← Compare landing

IDT Australia vs Stason Industrial Corporation

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryIDT AustraliaStason Industrial Corporation
SummaryIDT Australia is a cGMP CDMO delivering end-to-end pharmaceutical development and manufacturing services from active pharmaceutical ingredients to finished dosage forms, with expertise in small molecule APIs, specialty orals, advanced therapies, and integrated regulatory support.US-based CDMO offering contract packaging, analytical testing, and manufacturing services for clinical trial and commercial pharmaceutical production, with specialized high-containment capabilities for potent compounds.
Services
  • Regulatory Affairs
  • Small Molecule Development & Manufacturing
  • API Synthesis & Manufacturing
  • HPAPI Manufacturing (High-Potency)
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • ADC Payload & Linker Synthesis
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Lyophilization (Freeze Drying)
  • Oral Solid Dosage Manufacturing
  • Process Development
  • Formulation Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • Stability Testing & Storage
  • Secondary Packaging & Labeling
  • CMC Regulatory Submission Support
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • HPAPI Manufacturing (High-Potency)
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Lyophilization (Freeze Drying)
  • Oral Solid Dosage Manufacturing
  • CMC Analytical Development
  • Quality Control Testing
  • Stability Testing & Storage
  • Secondary Packaging & Labeling
Modalities
  • Small Molecule
  • Antibody-Drug Conjugate (ADC)
  • Radiopharmaceutical
  • Small Molecule
Development capabilities
  • Analytical method development
  • Formulation development
  • ICH stability testing
  • Analytical method development
  • ICH stability testing
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
  • Liquid Vials
  • Lyophilized Vials
  • Oral Solid Dose (OSD)
  • HPAPI
  • DEA licensed
  • Drug Substance (DS)
  • Drug Product (DP)
  • Oral Solid Dose (OSD)
  • Lyophilized Vials
  • Max chemical: Commercial (>100 kg / tonne)
  • HPAPI
Locations
  • Headquarters, Australia
  • Headquarters, Irvine, California, United States
  • Manufacturing Partner, Tainan, Taiwan
CertificationsData not yet provided.
  • FDA · Identifier: cGMP

Find similar companies

IDT Australia alternatives · Stason Industrial Corporation alternatives

Markdown mirror: /compare/idtaus-com/stasonpharma.md